{"TopicDetails": {"type": 0, "ccm2Id": 47032546, "cftId": 0, "identifier": "HORIZON-JU-IHI-2024-08-03-two-stage", "title": "Modelling regulatory sandbox mechanisms  and enabling their deployment to support breakthrough innovation", "publicationDateLong": 1719273600000, "callIdentifier": "HORIZON-JU-IHI-2024-08-two-stage", "callTitle": "Innovative Health Initiative JU Call 8", "callccm2Id": 47032605, "allowPartnerSearch": true, "frameworkProgramme": {"id": 43108390, "abbreviation": "HORIZON", "description": "Horizon Europe Framework Programme (HORIZON)"}, "programmeDivision": [{"id": 45177852, "abbreviation": "HORIZON.2.1.7", "description": "Innovative Health Initiative"}, {"id": 43108557, "abbreviation": "HORIZON.2.1", "description": "Health"}, {"id": 43108541, "abbreviation": "HORIZON.2", "description": "Global Challenges and European Industrial Competitiveness"}], "topicMGAs": [], "tags": ["IHI JU", "Innovative Heath Initiative Joint Undertaking", "Modelling regulatory sandbox mechanisms and enabling their deployment to support breakthrough innovation", "IHI", "Innovative Heath Initiative", "Joint Undertaking"], "keywords": ["Disruptive innovation", "Medicine", "Medical devices", "Regulatory framework for innovation", "Public Private Partnerships (PPP)", "Medical biotechnology"], "sme": false, "actions": [{"status": {"id": 31094502, "abbreviation": "Open", "description": "Open"}, "types": [{"typeOfAction": "HORIZON-JU-RIA HORIZON JU Research and Innovation Actions", "typeOfMGA": [{"id": 43027846, "abbreviation": "HORIZON-AG", "description": "HORIZON Action Grant Budget-Based"}]}], "plannedOpeningDate": "25 June 2024", "submissionProcedure": {"id": 31094505, "abbreviation": "two-stage", "description": "two-stage"}, "deadlineDates": ["10 October 2024", "23 April 2025"]}], "latestInfos": [], "budgetOverviewJSONItem": {"budgetTopicActionMap": {"3543165": [{"action": "HORIZON-JU-IHI-2024-08-02-two-stage - HORIZON-JU-RIA HORIZON JU Research and Innovation Actions", "plannedOpeningDate": "25 June 2024", "deadlineModel": "two-stage", "deadlineDates": ["10 October 2024", "23 April 2025"], "budgetYearMap": {"2024": 47550000}, "expectedGrants": 1, "minContribution": 14000000, "maxContribution": 14000000, "budgetTopicActionMap": {}}, {"action": "HORIZON-JU-IHI-2024-08-04-two-stage - HORIZON-JU-RIA HORIZON JU Research and Innovation Actions", "plannedOpeningDate": "25 June 2024", "deadlineModel": "two-stage", "deadlineDates": ["10 October 2024", "23 April 2025"], "budgetYearMap": {"2024": 47550000}, "expectedGrants": 1, "minContribution": 12600000, "maxContribution": 12600000, "budgetTopicActionMap": {}}, {"action": "HORIZON-JU-IHI-2024-08-03-two-stage - HORIZON-JU-RIA HORIZON JU Research and Innovation Actions", "plannedOpeningDate": "25 June 2024", "deadlineModel": "two-stage", "deadlineDates": ["10 October 2024", "23 April 2025"], "budgetYearMap": {"2024": 47550000}, "expectedGrants": 1, "minContribution": 5200000, "maxContribution": 5200000, "budgetTopicActionMap": {}}, {"action": "HORIZON-JU-IHI-2024-08-01-two-stage - HORIZON-JU-RIA HORIZON JU Research and Innovation Actions", "plannedOpeningDate": "25 June 2024", "deadlineModel": "two-stage", "deadlineDates": ["10 October 2024", "23 April 2025"], "budgetYearMap": {"2024": 47550000}, "expectedGrants": 1, "minContribution": 15750000, "maxContribution": 15750000, "budgetTopicActionMap": {}}]}, "budgetYearsColumns": ["2024"]}, "description": "<SPAN class=\"topicdescriptionkind\">ExpectedOutcome</SPAN>:<p>The action under this topic must contribute to all of the following outcomes:</p><ul level=\"0\"><li>A horizon scanning for potential sandbox candidates including how sandboxes provide an additional tool to existing frameworks and identified examples to model the process;</li><li>Analysis of how regulatory sandboxes can drive science and health technology innovation in an evolving environment;</li><li>Recommendations for end-to-end operations of regulatory sandboxes to inform healthcare innovation developers, regulators, and other decision makers.</li> </ul>\n<SPAN class=\"topicdescriptionkind\">Scope</SPAN>:<p>While there is no concrete definition, regulatory sandboxes generally refer to regulatory frameworks that provide a structure for healthcare innovation developers to test and experiment with new and innovative products, services, or approaches under the oversight of a regulator for a limited period of time. These adaptive tools are meant to address challenges arising from the acceleration of technological/scientific advances and the mechanisms intended to regulate them. It offers customisation in terms of how a regulatory framework can be applied, combined with appropriate safeguards.</p><p>Regulatory sandboxes, first tested in the fintech sector (2015), are starting to transform the traditional methods used by regulatory agencies in the health sector to accompany the development of safe, efficacious, and high-quality health technologies<sup><strong>1</strong></sup>, which, due to their level of novelty, challenge the current regulatory framework. The mechanism enables breakthrough developments and the testing of alternative regulatory approaches for disruptive innovations for medicinal products, related platforms and their combinations, including where appropriate medical and digital technologies. Regulatory sandboxes are mentioned as important future-proofing elements in the legislative proposal<sup><strong>2</strong></sup> of the European Commission on the general pharmaceutical legislation. The European Commission\u2019s communication to boost biotechnology and biomanufacturing in the EU further promotes the establishment of regulatory sandboxes that allow the testing of novel solutions in a controlled environment for a limited amount of time under the supervision of regulators as a way of quickly bringing more of them to the market<sup><strong>3</strong></sup>. Regulatory sandboxes are not featured in the medical devices and <em>in vitro</em> diagnostics regulations (MDR and IVDR)<sup><strong>4</strong></sup>, but the artificial intelligence (AI) Act<sup><strong>5</strong></sup> creates an opportunity for regulatory sandboxes focused on case studies for AI-enabled medical devices. Regulatory sandboxes entail a shared learning objective for innovators (finding a pathway and getting regulatory predictability) and regulators (understanding the technology and defining how best to regulate it). The mechanism helps to inform future regulation through experimentation and evidence generation and minimises the risks of regulating ex-ante innovative and novel approaches prematurely or inappropriately. For the same reasons regulatory sandboxes also potentially facilitate the more efficient or rapid subsequent adaptation of the legislation either through translation into an adapted regulatory framework and/or through recommendations when the time comes for revising existing or developing new legislation.</p><p>Regulatory sandboxes should be able to experiment and draw on several relevant healthcare innovation related frameworks other than pharmaceutical products (i.e. medical devices, <em>in-vitro</em> diagnostics, AI, digital health technologies, and substances of human origin among others). Due to their anticipatory and adaptive nature, regulatory sandboxes are well placed to address gaps and complexity within and across regulatory frameworks. Indeed, as the number of drug and device combinations increases, and technology integration becomes the norm rather than an exception in healthcare innovation R&amp;D, manufacturing and healthcare delivery, the current siloed technology-specific frameworks may not provide a clear path forward. To that end, when considering an innovation, it is important to consider all relevant legislative frameworks including MDR and IVDR, the Clinical Trials Regulation<sup><strong>6</strong></sup>, the General Product Safety Regulation<sup><strong>7</strong></sup> and AI ACT among others.</p><p>Although still new to the healthcare and pharmaceutical sector, there are a few examples of regulatory sandboxes such as the <a href=\"http://www.canada.ca/en/health-canada/corporate/about-health-canada/activities-responsibilities/strategies-initiatives/health-products-food-regulatory-modernization/advanced-therapeutic-products.html\">Sante Canada sandbox for advanced therapeutic products</a> or the <a href=\"http://www.moh.gov.sg/home/our-healthcare-system/licensing-experimentation-and-adaptation-programme-(leap)---a-moh-regulatory-sandbox\">Singapore sandbox to test telemedicine</a>. More recently, the UK launched the <a href=\"http://www.gov.uk/government/news/mhra-to-launch-the-ai-airlock-a-new-regulatory-sandbox-for-ai-developers\">MHRA AI-airlock</a> to assist in the development and deployment of software and AI medical devices, safely providing patients with earlier access to cutting edge innovations that improve care.</p><p>The overall aim of this IHI topic is to contribute to the progression and successful implementation of regulatory sandboxes for healthcare innovations by developing a comprehensive and shared understanding of their value and process of implementation. The topic should also enable the development of a cross-sectoral community of stakeholders including pharma and medical device companies, regulators, and health technology assessment bodies (HTAs), among other stakeholders.</p><p>To fulfil this aim, the proposal should:</p><p><strong>1. Scan the horizon for potential sandbox candidates including how sandboxes provide an additional tool to existing frameworks, and use the examples identified to model the process.</strong></p><p>To this end, a key objective is to identify a number of healthcare innovation case studies to better understand how a regulatory sandbox could be used to solve further-defined challenges at an existing regulation level and inform recommendations for end-to-end operations. These cases could draw from the past, present and from horizon scanning activities (the EMA\u2019s work in this area already provides a hint<sup><strong>8</strong></sup>) to anticipate future innovations, looking across their development value chain.</p><p><strong>2. Analyse how regulatory sandboxes can drive science and health technology innovation in an evolving environment.</strong></p><p>The proposal should do this by:</p><ul level=\"0\"><li>anticipating consequences for health technology development under a regulatory sandbox mechanism, acknowledging its time-limited scope and the consequences (considering the technical particularities of healthcare innovation) for other downstream activities e.g., standardisation, health technology assessment;</li><li>proactively identifying any guardrails and mitigation measures.</li> </ul><p><strong>3. Develop recommendations for end-to-end operations of regulatory sandboxes to inform healthcare innovation developers, regulators and downstream decision makers. </strong></p><p>The proposal should do this by:</p><ul level=\"0\"><li>mapping out conceptual elements and operationalisation features of future sandbox mechanisms based on existing experiences in other fields such as governance, conditions fostering dialogue and collaboration, access to the right type of expertise, support, regulatory customisation, sharing/communicating lessons learned and their translation via the appropriate frameworks into new standards, among other elements to be further defined;</li><li>modelling how to operationalise the sandbox(es) (including governance, operations, principles) and how they could be used in healthcare innovation development and evaluation in conjunction with existing regulatory mechanisms to advance innovation at European and national levels.</li> </ul><p>Part of the topic entails modelling a regulatory sandbox. The proposal should therefore consider good practices for designing and evaluating the necessary operating models to ensure the robustness and future applicability of the output of the project.</p><p>The project outcomes could also offer directions for the translation of the resulting recommendations into digital tools and systems deemed necessary for the functioning of regulatory sandboxes (e.g. ensuring collaboration between different health authorities\u2019 triage mechanisms, horizon scanning, fitness check evaluations), as relevant.</p><p>When developing a comprehensive and shared understanding of the value of regulatory sandboxes, applicants will have to explore key aspects across the life-cycle of healthcare innovations with the objective of accompanying their ultimate adoption, which could include as appropriate R&amp;D, regulatory authorities, HTA bodies, payers, governments, clinicians and patients. Ethical considerations would also have to be considered as some innovations could trigger questions in this field.A shared objective should include to develop a regulatory strategy and interaction plan for generating appropriate evidence, enabling engagement across all the different decision makers in a timely manner (e.g. national competent authorities, EMA and the respective Innovation Task Force, qualification advice) and identifying aspects that can be leveraged by existing regulatory tools, as well as the limiting aspects and the flexibilities that would be required under a regulatory sandbox to achieve the timely development and access of healthcare innovations.</p><p><sub><sup><strong>1 </strong></sup>\u2018health technology\u2019 means a medicinal product, a medical device or medical and surgical procedures as well as measures for disease prevention, diagnosis or treatment used in healthcare.</sub></p><p><sub><sup><strong>2</strong></sup> Proposal for a Regulation of the European Parliament and of the Council laying down Union procedures for the authorisation and supervision of medicinal products for human use and establishing rules governing the European Medicines Agency, amending Regulation (EC) No 1394/2007 and Regulation (EU) No 536/2014 and repealing Regulation (EC) No 726/2004, Regulation (EC) No 141/2000 and Regulation (EC) No 1901/2006 <a href=\"http://eur-lex.europa.eu/legal-content/EN/TXT/?uri=CELEX%3A52023PC0193\">Chapter IX Regulatory Sandbox (Articles 113-115)</a></sub></p><p><sub><sup><strong>3</strong></sup> <a href=\"http://research-and-innovation.ec.europa.eu/document/download/47554adc-dffc-411b-8cd6-b52417514cb3_en\">https://research-and-innovation.ec.europa.eu/document/download/47554adc-dffc-411b-8cd6-b52417514cb3_en</a></sub></p><p><sub><sup><strong>4 </strong></sup>Regulation (EU) 2017/745 of the European Parliament and of the Council of 5 April 2017 on medical devices and Regulation (EU) 2017/746 of the European Parliament and of the Council of 5 April 2017 on in vitro diagnostic medical devices.</sub></p><p><sub><sup><strong>5 </strong></sup>Regulation of the European Parliament and of the Council laying down harmonised rules on artificial intelligence (Artificial Intelligence Act).</sub></p><p><sub><sup><strong>6</strong></sup> Regulation (EU) No 536/2014 of the European Parliament and of the Council of 16 April 2014 on clinical trials on medicinal products for human use.</sub></p><p><sub><sup><strong>7 </strong></sup>Regulation (EU) 2023/988 of the European Parliament and of the Council of 10 May 2023 on general product safety.</sub></p><p><sub><strong><sup>8</sup></strong> Health horizons: Future trends and technologies from the European Medicines Agency\u2019s horizon scanning collaborations: <a href=\"http://www.frontiersin.org/articles/10.3389/fmed.2022.1064003/full\">https://doi.org/10.3389/fmed.2022.1064003</a>.</sub></p>\n<SPAN class=\"topicdescriptionkind\">Expected Impact</SPAN>:<p>The action under this topic is expected to achieve the following impacts:</p><ul level=\"0\"><li>Meaningful contributions to the successful implementation of regulatory sandboxes through developing a comprehensive and shared understanding of their use and value among key stakeholders in the healthcare ecosystem;</li><li>Support the future-proofing of the EU regulatory framework by design, enabling the efficient implementation of regulatory sandboxes where and when appropriate, and thus helping to make Europe more attractive as place of innovation;</li><li>Enhancing and enabling the cooperation of key healthcare stakeholders, including patients, clinicians, small and medium-sized enterprises (SMEs) and academics, with regulators in developing a competitive and innovation-friendly landscape;</li><li>Fostering interaction with regulators to develop healthcare solutions when it is not possible to develop them within the current framework.</li> </ul><p>The action will also contribute to a number of European policies/initiatives, which include:</p><ul level=\"0\"><li>the <a href=\"https://health.ec.europa.eu/medicinal-products/pharmaceutical-strategy-europe_en\">European Commission\u2019s Pharmaceutical Strategy</a><u><a href=\"https://health.ec.europa.eu/medicinal-products/pharmaceutical-strategy-europe_en\"> for Europe</a>, </u>specifically the pillar on competitiveness, innovation and sustainability;</li><li>related measures under the ongoing revision of the Pharmaceutical legislation;</li><li><a href=\"http://research-and-innovation.ec.europa.eu/strategy/support-policy-making/shaping-eu-research-and-innovation-policy/new-european-innovation-agenda_en\">the European Commission innovation agenda</a> (published in 2022) flagship initiative \u201c<em>Enabling innovation through experimentation spaces and public procurement</em>\u201d facilitating innovation through improved framework conditions including experimental approaches to regulation (e.g. regulatory sandboxes);</li><li>the EU biotech strategy;</li><li>the green and sustainability agenda.</li> </ul>\n", "conditions": "<h1><span style=\"color: rgb(0, 0, 0);\"><span style=\"font-size: medium;\"><span style=\"font-family: Arial;\"><b><span lang=\"EN-US\" style=\"line-height: 115%;\">General conditions</span></b></span></span></span></h1>\r\n<p class=\"MsoNormal\"><span style=\"font-size: small;\"><span style=\"font-family: Arial;\"><b><span lang=\"EN-US\">1. Admissibility conditions: </span></b><span lang=\"EN-US\">described in </span></span></span><span class=\"MsoHyperlink\"><span style=\"mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin\"><a href=\"https://ec.europa.eu/info/funding-tenders/opportunities/docs/2021-2027/horizon/wp-call/2023-2024/wp-13-general-annexes_horizon-2023-2024_en.pdf\" target=\"_blank\"><span style=\"font-size: small;\"><span style=\"font-family: Arial;\">Annex A</span></span></a></span></span><span style=\"font-size: small;\"><span style=\"font-family: Arial;\"><span lang=\"EN-US\"> </span><span style=\"color: rgb(0, 0, 0);\"><span lang=\"EN-US\">and </span></span></span></span><span class=\"MsoHyperlink\"><span style=\"mso-bidi-font-family:&#10;Calibri;mso-bidi-theme-font:minor-latin\"><a href=\"https://ec.europa.eu/info/funding-tenders/opportunities/docs/2021-2027/horizon/wp-call/2023-2024/wp-13-general-annexes_horizon-2023-2024_en.pdf\" target=\"_blank\"><span style=\"font-size: small;\"><span style=\"font-family: Arial;\">Annex E</span></span></a></span></span><span style=\"font-size: small;\"><span style=\"font-family: Arial;\"><span lang=\"EN-US\"> of the Horizon Europe Work Programme General Annexes</span></span></span></p>\r\n<p class=\"MsoNormal\">&nbsp;</p>\n<p style=\"margin-left: 40px;\"><span style=\"color: rgb(0, 0, 0);\"><span style=\"font-size: small;\"><span style=\"font-family: Arial;\"><b><span lang=\"EN-US\">Proposal page limits and layout:</span></b><span lang=\"EN-US\"> described in Part B of the Application Form available in the Submission System</span></span></span></span></p>\r\n<ul style=\"margin-top:0cm\" type=\"square\">\r\n    <li class=\"MsoNormal\">at      stage 1 of a two-stage Call, the limit for RIA short proposals is 20      pages;</li>\r\n</ul>\r\n<ul style=\"margin-top:0cm\" type=\"square\">\r\n    <li class=\"MsoNormal\">at      stage 2 of a two-stage Call, the limit for RIA full proposals is 50 pages.<b><o:p></o:p></b></li>\r\n</ul>\r\n<p>&nbsp;</p>\n<p><span style=\"color: rgb(0, 0, 0);\"><span style=\"font-size: small;\"><span style=\"font-family: Arial;\"><b><span lang=\"EN-US\">2. Eligible countries: </span></b><span lang=\"EN-US\">described in </span></span></span></span><span class=\"MsoHyperlink\"><span style=\"mso-bidi-font-family:Calibri;&#10;mso-bidi-theme-font:minor-latin\"><a href=\"https://ec.europa.eu/info/funding-tenders/opportunities/docs/2021-2027/horizon/wp-call/2023-2024/wp-13-general-annexes_horizon-2023-2024_en.pdf\" target=\"_blank\"><span style=\"font-size: small;\"><span style=\"font-family: Arial;\">Annex B</span></span></a></span></span><span style=\"font-size: small;\"><span style=\"font-family: Arial;\"><span lang=\"EN-US\"> </span></span></span><span style=\"color: rgb(0, 0, 0);\"><span style=\"font-size: small;\"><span style=\"font-family: Arial;\"><span lang=\"EN-US\">of the Work Programme General Annexes</span></span></span></span><span lang=\"EN-US\" style=\"mso-ansi-language:EN-US\"><o:p></o:p></span></p>\r\n<p class=\"MsoNormal\" style=\"margin-left: 40px;\"><span style=\"color: rgb(0, 0, 0);\"><span style=\"font-size: small;\"><span style=\"font-family: Arial;\"><span lang=\"EN-US\">A number of non-EU/non-Associated Countries that are not automatically eligible for funding have made specific provisions for making funding available for their participants in Horizon Europe projects. See the information in the </span></span></span></span><span class=\"MsoHyperlink\"><span style=\"mso-bidi-font-family:Calibri;mso-bidi-theme-font:&#10;minor-latin\"><a href=\"https://ec.europa.eu/info/funding-tenders/opportunities/docs/2021-2027/horizon/guidance/programme-guide_horizon_en.pdf\"><span style=\"font-size: small;\"><span style=\"font-family: Arial;\">Horizon Europe Programme Guide</span></span></a></span></span><span style=\"font-size: small;\"><span style=\"font-family: Arial;\"><span lang=\"EN-US\">.</span></span></span></p>\n<p><span style=\"color: rgb(0, 0, 0);\"><span style=\"font-size: small;\"><span style=\"font-family: Arial;\"><b style=\"mso-bidi-font-weight:normal\"><span lang=\"EN-US\">3. Other eligibility conditions:</span></b><span lang=\"EN-US\"> described in </span></span></span></span><span class=\"MsoHyperlink\"><span style=\"mso-bidi-font-family:&#10;Calibri;mso-bidi-theme-font:minor-latin\"><a href=\"https://ec.europa.eu/info/funding-tenders/opportunities/docs/2021-2027/horizon/wp-call/2023-2024/wp-13-general-annexes_horizon-2023-2024_en.pdf\" target=\"_blank\"><span style=\"font-size: small;\"><span style=\"font-family: Arial;\">Annex B</span></span></a></span></span><span style=\"color: rgb(0, 0, 0);\"><span style=\"font-size: small;\"><span style=\"font-family: Arial;\"> <span lang=\"EN-US\">of the Work Programme General Annexes&nbsp;</span></span></span></span><font face=\"Arial\" size=\"2\">and in the ''Conditions of the Calls for proposals and Calls management rules'' section of the <a href=\"https://www.ihi.europa.eu/sites/default/files/uploads/Documents/About/AWP/WorkProgramme2024_Amend1.pdf\" target=\"_blank\">IHI JU Work Programme (WP)</a></font></p>\n<p><span style=\"color: rgb(0, 0, 0);\"><span style=\"font-size: small;\"><span style=\"font-family: Arial;\"><b>4. Financial and operational capacity and exclusion: </b>described in </span></span></span><span style=\"mso-bidi-font-weight:bold\"><a href=\"https://ec.europa.eu/info/funding-tenders/opportunities/docs/2021-2027/horizon/wp-call/2023-2024/wp-13-general-annexes_horizon-2023-2024_en.pdf\" target=\"_blank\"><span style=\"font-size: small;\"><span style=\"font-family: Arial;\">Annex C</span></span></a></span><span style=\"color: rgb(0, 0, 0);\"><span style=\"font-size: small;\"><span style=\"font-family: Arial;\"> of the Work Programme General Annexes</span></span></span></p>\n<p><span style=\"color: rgb(0, 0, 0);\"><span style=\"font-size: small;\"><span style=\"font-family: Arial;\"><b><span lang=\"FR-BE\">5.&nbsp;Evaluation and award:</span></b></span></span></span></p>\n<ul style=\"margin-top:0cm\" type=\"square\">\r\n    <li class=\"MsoNormal\">\r\n    <p><span style=\"color: rgb(0, 0, 0);\"><span style=\"font-size: small;\"><span style=\"font-family: Arial;\"><b><span lang=\"EN-US\">Award criteria, scoring and      thresholds</span></b><span lang=\"EN-US\"> are      described in </span></span></span></span><span class=\"MsoHyperlink\"><a href=\"https://ec.europa.eu/info/funding-tenders/opportunities/docs/2021-2027/horizon/wp-call/2023-2024/wp-13-general-annexes_horizon-2023-2024_en.pdf\" target=\"_blank\"><span style=\"font-size: small;\"><span style=\"font-family: Arial;\">Annex      D</span></span></a></span><span style=\"font-size: small;\"><span style=\"font-family: Arial;\"><span lang=\"EN-US\"> </span><span style=\"color: rgb(0, 0, 0);\"><span lang=\"EN-US\">of      the Work Programme General Annexes&nbsp;</span></span></span></span><font face=\"Arial\" size=\"2\"><span lang=\"EN-US\"><o:p></o:p></span>and in the ''Conditions of the Calls for proposals and Calls management rules'' section of the <a href=\"https://www.ihi.europa.eu/sites/default/files/uploads/Documents/About/AWP/WorkProgramme2024_Amend1.pdf\" target=\"_blank\">IHI JU Work Programme (WP)</a></font></p>\r\n    </li>\r\n</ul>\n<ul style=\"margin-top:0cm\" type=\"square\">\r\n    <li class=\"MsoNormal\">\r\n    <p><span style=\"color: rgb(0, 0, 0);\"><span style=\"font-size: small;\"><span style=\"font-family: Arial;\"><b><span lang=\"EN-US\">Submission and evaluation      processes</span></b><span lang=\"EN-US\"> are      described in </span></span></span></span><span class=\"MsoHyperlink\"><a href=\"https://ec.europa.eu/info/funding-tenders/opportunities/docs/2021-2027/horizon/wp-call/2023-2024/wp-13-general-annexes_horizon-2023-2024_en.pdf\" target=\"_blank\"><span style=\"font-size: small;\"><span style=\"font-family: Arial;\">Annex      F</span></span></a></span><span style=\"color: rgb(0, 0, 0);\"><span style=\"font-size: small;\"><span style=\"font-family: Arial;\"><span lang=\"EN-US\"> of      the Work Programme General Annexes and the </span></span></span></span><a href=\"https://ec.europa.eu/info/funding-tenders/opportunities/docs/2021-2027/common/guidance/om_en.pdf\"><span style=\"font-size: small;\"><span style=\"font-family: Arial;\">Online      Manual</span></span></a><span lang=\"EN-US\"><o:p></o:p></span></p>\r\n    </li>\r\n</ul>\n<ul style=\"margin-top:0cm\" type=\"square\">\r\n    <li class=\"MsoNormal\">\r\n    <p><span style=\"color: rgb(0, 0, 0);\"><span style=\"font-size: small;\"><span style=\"font-family: Arial;\"><b><span lang=\"EN-US\">Indicative timeline for      evaluation and grant agreement: </span></b><span lang=\"EN-US\">described in </span></span></span></span><span class=\"MsoHyperlink\"><a href=\"https://ec.europa.eu/info/funding-tenders/opportunities/docs/2021-2027/horizon/wp-call/2023-2024/wp-13-general-annexes_horizon-2023-2024_en.pdf\" target=\"_blank\"><span style=\"font-size: small;\"><span style=\"font-family: Arial;\">Annex      F</span></span></a></span><span style=\"color: rgb(0, 0, 0);\"><span style=\"font-size: small;\"><span style=\"font-family: Arial;\"><span lang=\"EN-US\"> of the Work Programme General Annexes</span></span></span></span><span lang=\"EN-US\"><o:p></o:p></span></p>\r\n    </li>\r\n</ul>\n<p><span style=\"color: rgb(0, 0, 0);\"><span style=\"font-size: small;\"><span style=\"font-family: Arial;\"><b style=\"mso-bidi-font-weight:normal\"><span lang=\"EN-US\">6. Legal and financial set-up of the grants: </span></b><span lang=\"EN-US\">described in </span></span></span></span><span class=\"MsoHyperlink\"><span style=\"mso-bidi-font-family:Calibri;mso-bidi-theme-font:&#10;minor-latin\"><a href=\"https://ec.europa.eu/info/funding-tenders/opportunities/docs/2021-2027/horizon/wp-call/2023-2024/wp-13-general-annexes_horizon-2023-2024_en.pdf\" target=\"_blank\"><span style=\"font-size: small;\"><span style=\"font-family: Arial;\">Annex G</span></span></a></span></span><span style=\"color: rgb(0, 0, 0);\"><span style=\"font-size: small;\"><span style=\"font-family: Arial;\"><span lang=\"EN-US\"> of the Work Programme General Annexes</span></span></span></span></p>\r\n<p>&nbsp;</p>\n<h1><span style=\"font-size: medium;\"><span style=\"font-family: Arial;\"><b><span lang=\"EN-US\" style=\"line-height: 115%;\">Specific conditions</span></b></span></span><b><span lang=\"EN-US\" style=\"font-size:12.0pt;mso-bidi-font-size:&#10;11.0pt;line-height:115%;mso-ansi-language:EN-US\"><o:p></o:p></span></b></h1>\r\n<p class=\"MsoNormal\"><span style=\"color: rgb(0, 0, 0);\"><span style=\"font-size: small;\"><span style=\"font-family: Arial;\"><b><span lang=\"EN-US\">7. Specific conditions: </span></b><span lang=\"EN-US\">described in the&nbsp;</span></span></span></span><font face=\"Arial\" size=\"2\">''Conditions of the Calls for proposals and Calls management rules'' section of the <a href=\"https://www.ihi.europa.eu/sites/default/files/uploads/Documents/About/AWP/WorkProgramme2024_Amend1.pdf\" target=\"_blank\">IHI JU Work Programme (WP)</a></font></p>\r\n<ul>\r\n    <li>specific conditions on Availability, Accessibility and Affordability (3A) <strong>do not apply to this topic</strong></li>\r\n    <li>JU's right to object to transfer/exclusive licensing</li>\r\n</ul>\r\n<p class=\"MsoNormal\">&nbsp;</p>\r\n<p class=\"MsoNormal\"><span lang=\"EN-US\"><o:p></o:p></span></p>\n<h1><span style=\"font-size: medium;\"><b><span lang=\"EN-US\" style=\"line-height: 115%;\"><span style=\"font-family: Arial;\">Documents</span></span></b></span><b><span lang=\"EN-US\" style=\"font-size:12.0pt;mso-bidi-font-size:&#10;11.0pt;line-height:115%;mso-ansi-language:EN-US\"><o:p></o:p></span></b></h1>\r\n<div><b>Where relevant, templates of the reference documents and associated guidance can be found on <a href=\"https://www.ihi.europa.eu/apply-funding/call-documents\">the&nbsp;IHI JU&nbsp;website</a>.</b></div>\r\n<p class=\"MsoNormal\"><b>Regarding the application forms for submitting proposals, the relevant templates and annexes are available to download in the submission system.</b><o:p></o:p></p>\r\n<p class=\"MsoNormal\">&nbsp;<span lang=\"EN-US\">The IHI JU 8</span><sup>th</sup>&nbsp;<span lang=\"EN-US\">Call for proposals full topics text is available <a href=\"https://www.ihi.europa.eu/sites/default/files/uploads/Documents/Calls/IHI_Call8_CallText.pdf\">here</a>.</span></p>\r\n<p class=\"MsoNormal\"><b>Evaluation form (single and two-stage Calls)</b><o:p></o:p></p>\r\n<p class=\"MsoNormal\">-&nbsp;<a href=\"https://www.ihi.europa.eu/sites/default/files/uploads/Documents/Calls/IHI_Evaluation_form_RIA_UpdateDec2023.pdf\">IHI JU Evaluation form for Research and Innovation Actions&nbsp;</a>(single and two-stage Calls)<o:p></o:p></p>\r\n<p class=\"MsoNormal\"><b><span lang=\"EN-IE\">Proposal Templates Part A and Part B (Research and Innovation Actions &ndash; single-stage and second stage of two-stage procedure)&nbsp;</span></b><o:p></o:p></p>\r\n<p class=\"MsoNormal\">-&nbsp;&nbsp;<b><span lang=\"EN-IE\">Proposal template - Part A</span></b><span lang=\"EN-IE\">&nbsp;of the proposal is generated by the IT system in the submission environment (for more information see the HE Part A template&nbsp;</span><a href=\"https://ec.europa.eu/info/funding-tenders/opportunities/docs/2021-2027/horizon/temp-form/af/af_he-ria-ia_en.pdf\"><span lang=\"EN-IE\">here</span></a><span lang=\"EN-IE\">). In Part A of the proposal applicants insert general information on their proposal (e.g. proposal acronym), details on the participants and the overall proposal budget. <br />\r\nPlease note that&nbsp;<strong>only&nbsp;</strong>Part A of this template is applicable for this call. For Part B, see point below.</span><o:p></o:p></p>\r\n<p class=\"MsoNormal\"><span lang=\"FR-BE\">- <a href=\"https://www.ihi.europa.eu/sites/default/files/IHI_Proposal_template_RIA_SP_PartB.pdf\">IHI JU Proposal template (RIA/SP) &ndash; Part B</a>&nbsp;&nbsp;<o:p></o:p></span><b><u><span lang=\"EN-IE\">(applicable to the first-stage of two-stage Calls)</span></u></b></p>\r\n<p class=\"MsoNormal\">-&nbsp;<span lang=\"EN-IE\"><a href=\"https://www.ihi.europa.eu/sites/default/files/uploads/Documents/Calls/IHI_Proposal_template_RIA_FP_PartB_UpdateJune2024.pdf\" target=\"_blank\">IHI JU Proposal template (RIA/FP) - Part B</a></span>&nbsp;<b><u><span lang=\"EN-IE\">(applicable to the second stage of two-stage Calls)</span></u></b><o:p></o:p></p>\r\n<p class=\"MsoNormal\"><o:p></o:p></p>\r\n<p class=\"MsoNormal\"><b>Proposal Annexes</b><o:p></o:p></p>\r\n<p class=\"MsoNormal\"><b>- Annex: Type of Participants</b><o:p></o:p></p>\r\n<p class=\"MsoNormal\">The&nbsp;<i>&ldquo;type of participants&rdquo;</i>&nbsp;is an IHI specific annex.<o:p></o:p></p>\r\n<p class=\"MsoNormal\">The excel template for:<o:p></o:p></p>\r\n<p class=\"MsoNormal\">-&nbsp;short proposals (first stage of two-stage calls) can be found&nbsp;<a href=\"https://www.ihi.europa.eu/sites/default/files/uploads/Documents/Calls/IHI_Annex_Type_of_participants_Stage1.xlsx\">here</a>&nbsp;and<o:p></o:p></p>\r\n<p class=\"MsoNormal\">-&nbsp;full proposals (single-stage calls, and second stage of two-stage calls) can be found&nbsp;<a href=\"https://www.ihi.europa.eu/sites/default/files/IHI_Annex_Type_of_participants.xlsx\">here</a>&nbsp;<o:p></o:p></p>\r\n<p class=\"MsoNormal\">The instructions on how to fill in this template can be found&nbsp;<a href=\"https://www.ihi.europa.eu/sites/default/files/IHI_Annex_Type_of_participants_instrucctions.pdf\">here</a>.<o:p></o:p></p>\r\n<p class=\"MsoNormal\"><i>This is a compulsory annex, and it must be uploaded as a separate document in the submission system.</i><o:p></o:p></p>\r\n<p class=\"MsoNormal\">This annex is applicable to single-stage and in both stages of two-stage Calls.<o:p></o:p></p>\r\n<p class=\"MsoNormal\"><b><span lang=\"EN-IE\">- Annex: Declaration of in-kind contribution commitment</span></b><o:p></o:p></p>\r\n<p class=\"MsoNormal\">The &ldquo;<i>Declaration of in-kind contribution commitment&rdquo;</i>&nbsp;is an IHI specific annex and it is applicable to the single stage and second stage of two-stage Calls.<o:p></o:p></p>\r\n<p class=\"MsoNormal\">The word document template can be found&nbsp;<a href=\"https://www.ihi.europa.eu/sites/default/files/IHI_Annex_declaration_in_kind_contribution_commitment%20.pdf\">here</a>.<o:p></o:p></p>\r\n<p class=\"MsoNormal\"><i>This is a is a compulsory annex and it must be uploaded as a separate document in the submission system.</i><o:p></o:p></p>\r\n<p class=\"MsoNormal\"><b><span lang=\"EN-IE\">- Annex: In-kind contributions to additional activities (IKAA)</span></b><o:p></o:p></p>\r\n<p class=\"MsoNormal\">The &lsquo;<i>&rsquo;In-kind contributions to additional activities (IKAA)&rsquo;&rsquo;</i>&nbsp;is an IHI specific annex. The excel template can be found&nbsp;<a href=\"https://www.ihi.europa.eu/sites/default/files/uploads/Documents/Calls/IHI_Annex_declaration_in_kind_contribution_additional_activities_UpdateDec2023.xlsx\">here</a>&nbsp;and the instructions on how to fill in this template can be found&nbsp;<a href=\"https://www.ihi.europa.eu/sites/default/files/IHI_Annex_declaration_in_kind_contribution_additional_activities_instructions.pdf\">here</a>.<o:p></o:p></p>\r\n<p class=\"MsoNormal\"><i>This is an optional annex and&nbsp;it is applicable to the single stage and second stage of two-stage Calls.</i><o:p></o:p></p>\r\n<p class=\"MsoNormal\"><b><span lang=\"EN-IE\">- Annex: Essential information for clinical studies</span></b><o:p></o:p></p>\r\n<p class=\"MsoNormal\">The information on clinical studies is a Horizon Europe annex.<o:p></o:p></p>\r\n<p class=\"MsoNormal\"><i>This is a is a compulsory annex and it must be uploaded as a separate document in the submission system.</i><o:p></o:p></p>\r\n<p class=\"MsoNormal\">If your proposal does not include clinical studies,&nbsp;<u>please upload a statement declaring your proposal does not include clinical studies.</u><o:p></o:p></p>\r\n<p class=\"MsoNormal\">The information on clinical studies annex can be found&nbsp;<a href=\"https://ec.europa.eu/info/funding-tenders/opportunities/docs/2021-2027/horizon/temp-form/af/information-on-clinical-studies_he_en.docx\">here</a>:<o:p></o:p></p>\r\n<p class=\"MsoNormal\"><i>The annex&nbsp;is applicable to the single stage and second stage of two-stage Calls</i><i><span lang=\"EN-IE\">.</span></i><o:p></o:p></p>\r\n<p class=\"MsoNormal\"><b><span lang=\"EN-IE\">- Annex: Ethics</span></b><o:p></o:p></p>\r\n<p class=\"MsoNormal\">This is a HE annex. Ethics self-assessment should be included in proposal part A. However, in Calls where several serious ethics issues are expected, the characters limit in this section of proposal part A may not be sufficient for participants to give all necessary information. In those cases, participants may include additional information in an annex to proposal part B.&nbsp;<o:p></o:p></p>\r\n<p class=\"MsoNormal\"><i>This is an optional annex and&nbsp;it is applicable to the single stage and second stage of two-stage Calls.</i><o:p></o:p></p>\r\n<p class=\"MsoNormal\"><b><span lang=\"EN-IE\">- Annex to the budget for the Full Proposal&nbsp;</span></b><o:p></o:p></p>\r\n<p class=\"MsoNormal\"><i>This is a compulsory&nbsp;</i><a href=\"https://www.ihi.europa.eu/sites/default/files/uploads/Documents/Calls/Annex_Budget_for_full_Proposal_TWO_stage_call_UpdateDec2023.xlsx\"><i>Annex</i></a><u>,</u>&nbsp;which complements the budget figures already included in the proposal budget in PART A. Its purpose is to correctly guide the consortium in providing IHI-specific budget items (e.g. IKOP, IKAA, FC PAID, FC RECEIVED, etc.) and to comply with IHI additional eligibility criteria (e.g. 45% industry contribution).<o:p></o:p></p>\r\n<p class=\"MsoNormal\"><i>The annex is applicable to the</i>&nbsp;<i>single stage and second stage of two-stage Calls</i><o:p></o:p></p>\r\n<p class=\"MsoNormal\">&nbsp;&nbsp;<b>Model Grant Agreement (MGA)</b><o:p></o:p></p>\r\n<p class=\"MsoNormal\">&nbsp;</p>\r\n<p class=\"MsoNormal\">&nbsp;-&nbsp;<a href=\"https://ec.europa.eu/info/funding-tenders/opportunities/docs/2021-2027/common/agr-contr/general-mga_horizon-euratom_en.pdf\">HE&nbsp;General MGA v1.0</a><o:p></o:p></p>\n<h2><span style=\"color: rgb(0, 0, 0);\"><span style=\"font-size: small;\"><span style=\"font-family: Arial;\"><b><span lang=\"EN-US\">Additional documents:</span></b></span></span></span></h2>\r\n<h2><b><span lang=\"EN-US\"><o:p></o:p></span></b></h2>\r\n<p class=\"MsoNormal\"><b>-&nbsp;<a href=\"https://eur-lex.europa.eu/eli/reg/2021/2085\">Council Regulation (EU) 2021/2085 of 19 November 2021 establishing the Joint Undertakings under Horizon Europe and repealing Regulations (EC) No 219/2007, (EU) No 557/2014, (EU) No 558/2014, (EU) No 559/2014, (EU) No 560/2014, (EU) No 561/2014 and (EU) No 642/2014</a>&nbsp;&nbsp;(in short Single Basic Act &lsquo;SBA&rsquo; or Council Regulation (EU) 2021/2085).</b><o:p></o:p></p>\r\n<p class=\"MsoNormal\">- <a href=\"https://www.ihi.europa.eu/sites/default/files/uploads/Documents/About/AWP/WorkProgramme2024_Amend1.pdf\">IHI JU Work Programme (WP)</a><b><o:p></o:p></b></p>\r\n<p class=\"MsoNormal\">-&nbsp;<a href=\"https://www.ihi.europa.eu/sites/default/files/flmngr/IHI_Strategic_Research_and_Innovation_Agenda_3.pdf\">Strategic Research and Innovation Agenda (SRIA)</a><o:p></o:p></p>\r\n<p class=\"MsoNormal\">-&nbsp;<a href=\"https://www.ihi.europa.eu/sites/default/files/IHI_Guide_for_Applicants.pdf\" target=\"_blank\">IHI JU Guide for Applicants</a><o:p></o:p></p>\r\n<p class=\"MsoNormal\">-&nbsp;<a href=\"https://www.ihi.europa.eu/sites/default/files/uploads/Documents/Calls/Call_FAQs.pdf\" target=\"_blank\">IHI&nbsp;JU&nbsp;FAQs</a><o:p></o:p></p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom:0cm;margin-bottom:.0001pt\"><b>Horizon Europe Reference Documents</b></p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom:0cm;margin-bottom:.0001pt\"><a href=\"https://ec.europa.eu/info/funding-tenders/opportunities/docs/2021-2027/horizon/wp-call/2023-2024/wp-1-general-introduction_horizon-2023-2024_en.pdf\" target=\"_blank\"><span style=\"font-size: small;\"><span style=\"font-family: Arial;\">HE Main Work Programme 2023&ndash;2024 &ndash; 1. General Introduction</span></span></a></p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom:0cm;margin-bottom:.0001pt\"><a href=\"https://ec.europa.eu/info/funding-tenders/opportunities/docs/2021-2027/horizon/wp-call/2023-2024/wp-2-msca-actions_horizon-2023-2024_en.pdf\" target=\"_blank\"><span style=\"font-size: small;\"><span style=\"font-family: Arial;\">HE Main Work Programme 2023&ndash;2024 &ndash; 2. Marie Sk\u0142odowska-Curie Actions</span></span></a></p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom:0cm;margin-bottom:.0001pt\"><a href=\"https://ec.europa.eu/info/funding-tenders/opportunities/docs/2021-2027/horizon/wp-call/2023-2024/wp-3-research-infrastructures_horizon-2023-2024_en.pdf\" target=\"_blank\"><span style=\"font-size: small;\"><span style=\"font-family: Arial;\">HE Main Work Programme 2023&ndash;2024 &ndash; 3. Research Infrastructures</span></span></a></p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom:0cm;margin-bottom:.0001pt\"><a href=\"https://ec.europa.eu/info/funding-tenders/opportunities/docs/2021-2027/horizon/wp-call/2023-2024/wp-4-health_horizon-2023-2024_en.pdf\" target=\"_blank\"><span style=\"font-size: small;\"><span style=\"font-family: Arial;\">HE Main Work Programme 2023&ndash;2024 &ndash; 4. Health</span></span></a></p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom:0cm;margin-bottom:.0001pt\"><a href=\"https://ec.europa.eu/info/funding-tenders/opportunities/docs/2021-2027/horizon/wp-call/2023-2024/wp-5-culture-creativity-and-inclusive-society_horizon-2023-2024_en.pdf\" target=\"_blank\"><span style=\"font-size: small;\"><span style=\"font-family: Arial;\">HE Main Work Programme 2023&ndash;2024 &ndash; 5. Culture, creativity and inclusive society</span></span></a></p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom:0cm;margin-bottom:.0001pt\"><a href=\"https://ec.europa.eu/info/funding-tenders/opportunities/docs/2021-2027/horizon/wp-call/2023-2024/wp-6-civil-security-for-society_horizon-2023-2024_en.pdf\" target=\"_blank\"><span style=\"font-size: small;\"><span style=\"font-family: Arial;\">HE Main Work Programme 2023&ndash;2024 &ndash; 6. Civil Security for Society</span></span></a></p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom:0cm;margin-bottom:.0001pt\"><a href=\"https://ec.europa.eu/info/funding-tenders/opportunities/docs/2021-2027/horizon/wp-call/2023-2024/wp-7-digital-industry-and-space_horizon-2023-2024_en.pdf\" target=\"_blank\"><span style=\"font-size: small;\"><span style=\"font-family: Arial;\">HE Main Work Programme 2023&ndash;2024 &ndash; 7. Digital, Industry and Space</span></span></a></p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom:0cm;margin-bottom:.0001pt\"><a href=\"https://ec.europa.eu/info/funding-tenders/opportunities/docs/2021-2027/horizon/wp-call/2023-2024/wp-8-climate-energy-and-mobility_horizon-2023-2024_en.pdf\" target=\"_blank\"><span style=\"font-size: small;\"><span style=\"font-family: Arial;\">HE Main Work Programme 2023&ndash;2024 &ndash; 8. Climate, Energy and Mobility</span></span></a></p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom:0cm;margin-bottom:.0001pt\"><a href=\"https://ec.europa.eu/info/funding-tenders/opportunities/docs/2021-2027/horizon/wp-call/2023-2024/wp-9-food-bioeconomy-natural-resources-agriculture-and-environment_horizon-2023-2024_en.pdf\" target=\"_blank\"><span style=\"font-size: small;\"><span style=\"font-family: Arial;\">HE Main Work Programme 2023&ndash;2024 &ndash; 9. Food, Bioeconomy, Natural Resources, Agriculture and Environment</span></span></a></p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom:0cm;margin-bottom:.0001pt\"><a href=\"https://ec.europa.eu/info/funding-tenders/opportunities/docs/2021-2027/horizon/wp-call/2023-2024/wp-10-european-innovation-ecosystems_horizon-2023-2024_en.pdf\" target=\"_blank\"><span style=\"font-size: small;\"><span style=\"font-family: Arial;\">HE Main Work Programme 2023&ndash;2024 &ndash; 10. European Innovation Ecosystems (EIE)</span></span></a></p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom:0cm;margin-bottom:.0001pt\"><a href=\"https://ec.europa.eu/info/funding-tenders/opportunities/docs/2021-2027/horizon/wp-call/2023-2024/wp-11-widening-participation-and-strengthening-the-european-research-area_horizon-2023-2024_en.pdf\" target=\"_blank\"><span style=\"font-size: small;\"><span style=\"font-family: Arial;\">HE Main Work Programme 2023&ndash;2024 &ndash; 11. Widening participation and strengthening the European Research Area</span></span></a></p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom:0cm;margin-bottom:.0001pt\"><a href=\"https://ec.europa.eu/info/funding-tenders/opportunities/docs/2021-2027/horizon/wp-call/2023-2024/wp-12-missions_horizon-2023-2024_en.pdf\" target=\"_blank\"><span style=\"font-size: small;\"><span style=\"font-family: Arial;\">HE Main Work Programme 2023&ndash;2024 &ndash; 12. Missions</span></span></a></p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom:0cm;margin-bottom:.0001pt\"><a href=\"https://ec.europa.eu/info/funding-tenders/opportunities/docs/2021-2027/horizon/wp-call/2023-2024/wp-13-general-annexes_horizon-2023-2024_en.pdf\" target=\"_blank\"><span style=\"font-size: small;\"><span style=\"font-family: Arial;\">HE Main Work Programme 2023&ndash;2024 &ndash; 13. General Annexes</span></span></a></p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom:0cm;margin-bottom:.0001pt\"><a href=\"https://ec.europa.eu/info/funding-tenders/opportunities/docs/2021-2027/horizon/guidance/programme-guide_horizon_en.pdf\"><span style=\"font-size: small;\"><span style=\"font-family: Arial;\">HE Programme Guide</span></span></a></p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom:0cm;margin-bottom:.0001pt\"><a href=\"https://eur-lex.europa.eu/legal-content/EN/ALL/?uri=CELEX:32021R0695\" target=\"_blank\" style=\"font-family: Arial;\"><span style=\"font-size: small;\">HE Framework Programme and Rules for Participation Regulation 2021/695</span></a></p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom:0cm;margin-bottom:.0001pt\"><span style=\"font-family: Arial;\"><span lang=\"EN-US\" style=\"color: rgb(64, 64, 64);\"><a href=\"https://eur-lex.europa.eu/legal-content/EN/ALL/?uri=CELEX:32021D0764\" target=\"_blank\"><span style=\"font-size: small;\">HE Specific Programme Decision 2021/764</span></a></span></span></p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom:0cm;margin-bottom:.0001pt\"><a href=\"https://eur-lex.europa.eu/legal-content/EN/ALL/?uri=CELEX:32018R1046&amp;qid=1535046024012\"><span style=\"font-size: small;\"><span style=\"font-family: Arial;\"><span lang=\"EN-US\">EU Financial Regulation</span></span></span></a></p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom:0cm;margin-bottom:.0001pt\"><a href=\"https://ec.europa.eu/info/funding-tenders/opportunities/docs/2021-2027/common/guidance/rules-lev-lear-fca_en.pdf\"><span style=\"font-size: small;\"><span style=\"font-family: Arial;\">Rules for Legal Entity Validation, LEAR Appointment and Financial Capacity Assessment</span></span></a></p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom:0cm;margin-bottom:.0001pt\"><a href=\"https://ec.europa.eu/info/funding-tenders/opportunities/docs/2021-2027/common/guidance/aga_en.pdf\"><span style=\"font-size: small;\"><span style=\"font-family: Arial;\"><span lang=\"EN-US\">EU Grants AGA </span>&mdash; Annotated Model Grant Agreement</span></span></a></p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom:0cm;margin-bottom:.0001pt\"><a href=\"https://ec.europa.eu/info/funding-tenders/opportunities/docs/2021-2027/common/guidance/om_en.pdf\"><span style=\"font-size: small;\"><span style=\"font-family: Arial;\"><span lang=\"EN-US\">Funding &amp; Tenders Portal Online Manual</span></span></span></a></p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom:0cm;margin-bottom:.0001pt\"><a href=\"https://ec.europa.eu/info/funding-tenders/opportunities/docs/2021-2027/common/ftp/tc_en.pdf\"><span style=\"font-size: small;\"><span style=\"font-family: Arial;\">Funding &amp; Tenders Portal Terms and Conditions</span></span></a></p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom:0cm;margin-bottom:.0001pt\"><a href=\"https://ec.europa.eu/info/funding-tenders/opportunities/docs/2021-2027/common/ftp/privacy-statement_en.pdf\" style=\"font-size: 11pt; font-family: Arial;\"><span style=\"font-size: small;\">Funding &amp; Tenders Portal Privacy Statement</span></a></p>", "supportInfo": "<p class=\"MsoNormal\">Please read carefully all provisions below before the preparation of your application.</p>\r\n<p class=\"MsoNormal\">All the information concerning the IHI JU Calls is also published on the&nbsp;<a href=\"https://www.ihi.europa.eu/apply-funding/call-documents\" target=\"_blank\">IHI JU website</a>.&nbsp;&nbsp;&nbsp;<o:p></o:p></p>\r\n<p class=\"MsoNormal\">All the questions pertaining to the IHI JU Calls are to be addressed to&nbsp;<a href=\"mailto:infodesk@ihi.europa.eu\">infodesk@ihi.europa.eu</a>.<o:p></o:p></p>\r\n<p><strong><span style=\"font-size:9.0pt;font-family:&quot;Arial&quot;,sans-serif;&#10;font-weight:normal;mso-bidi-font-weight:bold\"><b><a href=\"https://ec.europa.eu/info/funding-tenders/opportunities/docs/2021-2027/common/guidance/om_en.pdf\" target=\"_blank\">Online Manual</a>&nbsp;</b></span></strong><span style=\"font-size: 9pt; font-family: Arial, sans-serif;\">is your guide on the procedures from proposal submission to managing your grant.<o:p></o:p></span></p>\r\n<p><a href=\"https://ec.europa.eu/info/funding-tenders/opportunities/docs/2021-2027/horizon/guidance/programme-guide_horizon_en.pdf\" target=\"_blank\"><b><span style=\"font-size:9.0pt;font-family:&quot;Arial&quot;,sans-serif\">Horizon Europe Programme Guide</span></b></a><strong><span style=\"font-size: 9pt; font-family: Arial, sans-serif;\">&nbsp;</span></strong><strong><span style=\"font-size: 9pt; font-family: Arial, sans-serif; font-weight: normal;\">contains the detailed guidance to the structure, budget and political priorities of Horizon Europe.</span></strong><span style=\"font-size: 9pt; font-family: Arial, sans-serif;\"><o:p></o:p></span></p>\r\n<p><span class=\"MsoHyperlink\"><b><span style=\"font-size:9.0pt;font-family:&quot;Arial&quot;,sans-serif\"><a href=\"https://ec.europa.eu/info/funding-tenders/opportunities/portal/screen/support/faq;type=undefined;categories=;programme=H2020;actions=;keyword=\" target=\"_blank\">Funding &amp; Tenders Portal FAQ</a></span></b></span><span style=\"font-size: 9pt; font-family: Arial, sans-serif;\">&nbsp;&ndash; find the answers to most frequently asked questions on submission of proposals, evaluation and grant management.<o:p></o:p></span></p>\r\n<p><span class=\"MsoHyperlink\"><b><span style=\"font-size:9.0pt;font-family:&quot;Arial&quot;,sans-serif\"><a href=\"https://ec.europa.eu/info/research-and-innovation/contact/research-enquiry-service_en\" target=\"_blank\">Research Enquiry Service</a></span>&nbsp;</b></span><span style=\"font-size: 9pt; font-family: Arial, sans-serif;\">&ndash; ask questions about any aspect of European research in general and the EU Research Framework Programmes in particular.</span></p>\r\n<p><span style=\"font-size: 9pt; font-family: Arial, sans-serif;\"><o:p></o:p></span></p>\r\n<p><b><span style=\"font-size: 9pt; font-family: Arial, sans-serif;\"><a href=\"https://ec.europa.eu/info/funding-tenders/opportunities/portal/screen/support/ncp\" target=\"_blank\">National Contact Points (NCPs)</a>&nbsp;</span></b><span style=\"font-size: 9pt; font-family: Arial, sans-serif;\">&ndash; get guidance, practical information and assistance on participation in Horizon Europe. There are also NCPs in many non-EU and non-associated countries (&lsquo;third-countries&rsquo;).<b><o:p></o:p></b></span></p>\r\n<p><a href=\"https://een.ec.europa.eu/\" target=\"_blank\"><b><span style=\"font-size:9.0pt;font-family:&quot;Arial&quot;,sans-serif\">Enterprise Europe Network</span></b></a><strong><span style=\"font-size:9.0pt;font-family:&quot;Arial&quot;,sans-serif;&#10;color:#003366\">&nbsp;</span></strong><span style=\"font-size: 9pt; font-family: Arial, sans-serif;\">&ndash; contact your EEN national contact for advice to businesses with special focus on SMEs. The support includes guidance on the EU research funding.<o:p></o:p></span></p>\r\n<p><span class=\"MsoHyperlink\"><b><span style=\"font-size:9.0pt;font-family:&quot;Arial&quot;,sans-serif\"><a href=\"https://ec.europa.eu/info/funding-tenders/opportunities/portal/screen/support/helpdesks/contact-form\" target=\"_blank\">IT Helpdesk</a></span></b>&nbsp;</span><span style=\"font-size: 9pt; font-family: Arial, sans-serif;\">&ndash;&nbsp;contact the Funding &amp; Tenders Portal IT helpdesk for questions such as forgotten passwords, access rights and roles, technical aspects of submission of proposals, etc.<o:p></o:p></span></p>\r\n<p><span class=\"MsoHyperlink\"><b><span style=\"font-size:9.0pt;font-family:&quot;Arial&quot;,sans-serif\"><a href=\"https://www.iprhelpdesk.eu/\" target=\"_blank\">European IPR Helpdesk</a></span></b></span><span style=\"font-size: 9pt; font-family: Arial, sans-serif;\">&nbsp;assists you on intellectual property issues.<br />\r\n<br />\r\n</span><b><a href=\"mailto:research@cencenelec.eu\" target=\"_blank\">CEN-CENELEC Research Helpdesk</a> and <a href=\"https://www.etsi.org/research/helpdesk\" target=\"_blank\">ETSI Research Helpdesk</a></b>&nbsp;<span style=\"font-family: Arial, sans-serif;\">&ndash;&nbsp;</span>the European Standards Organisations&nbsp;advise you how to tackle standardisation in your project proposal.&nbsp;&nbsp;</p>\r\n<p class=\"MsoNormal\" style=\"margin-left:36.0pt\"><o:p></o:p></p>\r\n<p><span class=\"MsoHyperlink\"><b><span style=\"font-size:9.0pt;font-family:&quot;Arial&quot;,sans-serif\"><a href=\"https://euraxess.ec.europa.eu/sites/default/files/am509774cee_en_e4.pdf\" target=\"_blank\">The European Charter for Researchers and the Code of Conduct for their recruitment</a></span></b></span><span style=\"font-size:&#10;9.0pt;font-family:&quot;Arial&quot;,sans-serif;color:#003366\"> </span><strong><span style=\"font-size:9.0pt;font-family:&quot;Arial&quot;,sans-serif;color:#003366;font-weight:&#10;normal;mso-bidi-font-weight:bold\">&ndash; consult the general principles and requirements specifying the roles, responsibilities and entitlements of researchers, employers and funders of researchers.</span></strong><b><span style=\"font-size: 9pt; font-family: Arial, sans-serif;\"><o:p></o:p></span></b></p>\r\n<p><span class=\"MsoHyperlink\"><b><span style=\"font-size:9.0pt;font-family:&quot;Arial&quot;,sans-serif\"><a href=\"https://ec.europa.eu/info/funding-tenders/opportunities/portal/screen/how-to-participate/partner-search\" target=\"_blank\">Partner Search Services</a></span></b></span><span style=\"font-size: 9pt; font-family: Arial, sans-serif;\">&nbsp;help you find a partner organisation for your proposal.<o:p></o:p></span></p>\r\n<p>&nbsp;</p>", "sepTemplate": "<p>The submission system is planned to be opened on the date stated on the topic header.</p>\r\n<p>\r\n<p class=\"MsoNormal\">To access the Electronic Submission Service, please click on the submission-button next to the&nbsp;<b>type of action</b>&nbsp;and the&nbsp;<b>type of model grant agreement</b>&nbsp;that corresponds to your proposal. You will then be asked to confirm your choice, as it cannot be changed in the submission system. Upon confirmation, you will be linked to the correct entry point.<o:p></o:p></p>\r\n<p class=\"MsoNormal\">To access existing draft proposals for this topic, please login to the Funding &amp; Tenders Portal and select the My Proposals page of the My Area section.<o:p></o:p></p>\r\n</p>", "links": [{"callIdentifier": "HORIZON-JU-IHI-2024-08-two-stage", "status": "Open", "criterionType": "SubFundingScheme", "criterionTypeDescription": "subfunding schemes", "criterionCode": "HORIZON-JU-RIA", "criterionDescription": "HORIZON JU Research and Innovation Actions", "url": "https://ec.europa.eu/research/participants/submission/manage/screen/submission/create-draft/36939?topic=HORIZON-JU-IHI-2024-08-03-two-stage", "startDate": "Jun 25, 2024 12:00:00 AM", "endDate": "Oct 10, 2024 5:00:00 PM", "mgaDescription": "HORIZON Action Grant Budget-Based", "mgaCode": "HORIZON-AG"}], "additionalDossiers": [], "infoPackDossiers": [], "callDetailsJSONItem": {"latestInfos": [{"approvalDate": "Jun 25, 2024 12:00:01 AM", "lastChangeDate": "Jun 25, 2024 12:00:01 AM", "content": "The submission session is now available for: HORIZON-JU-IHI-2024-08-03-two-stage(HORIZON-JU-RIA), HORIZON-JU-IHI-2024-08-01-two-stage(HORIZON-JU-RIA), HORIZON-JU-IHI-2024-08-02-two-stage(HORIZON-JU-RIA), HORIZON-JU-IHI-2024-08-04-two-stage(HORIZON-JU-RIA)"}], "hasForthcomingTopics": false, "hasOpenTopics": true, "allClosedTopics": false}}}